Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma

BACKGROUND: Despite some successes with checkpoint inhibitors for treating cancer, most patients remain refractory to treatment, possibly due to the inhibitory nature of the tumor stroma that impedes the function and entry of effector cells. We devised a new technique of combining immunotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Barsoumian, Hampartsoum B, Ramapriyan, Rishab, Younes, Ahmed I, Caetano, Mauricio S, Menon, Hari, Comeaux, Nathan I, Cushman, Taylor R, Schoenhals, Jonathan E, Cadena, Alexandra P, Reilly, Timothy P, Chen, Dawei, Masrorpour, Fatemeh, Li, Ailin, Hong, David S, Diab, Adi, Nguyen, Quynh-Nhu, Glitza, Isabella, Ferrarotto, Renata, Chun, Stephen G, Cortez, Maria Angelica, Welsh, James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592253/
https://www.ncbi.nlm.nih.gov/pubmed/33106386
http://dx.doi.org/10.1136/jitc-2020-000537

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592253/
https://www.ncbi.nlm.nih.gov/pubmed/33106386
http://dx.doi.org/10.1136/jitc-2020-000537

Ejemplares similares